Baldwin Insurance BWIN
- Market cap
- $4.5B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.6×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $1.7B
- +19% on a year ago
- Net margin
- −4.7%
- Free cash flow yield
- 1.0%
Baldwin Insurance trades at 2.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $1.7B over the last twelve months, up 19% on a year earlier with a −5% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $306.3M | $284.6M | $380.4M+15% | $339.8M+14% | $338.9M+11% | $329.9M+16% | $413.4M+9% | $378.8M+12% | $365.4M+8% | $347.3M+5% | $532.2M+29% | $492.9M+30% | |
| $86K | −$29.7M−55% | $34.3M+847% | $16.5M | $15.4M+17814% | −$5.5M−82% | $56M+64% | $27.9M+70% | $3.2M−79% | −$13.2M+142% | −$101.3M | −$8.3M | |
| Interest expense | $30.6M+47% | $31.9M+26% | $31.5M+13% | $31.3M+8% | $31.3M+2% | $29.4M−8% | $30M−5% | $31.3M+0% | $31.1M−1% | $29M−2% | $38.9M+30% | $45.7M+46% |
| Pre-tax income | −$31.8M−32% | −$62.1M−32% | $39.8M | −$29.4M−32% | −$14.5M−55% | −$35.3M−43% | $24.9M−37% | −$4.5M−85% | −$30.2M+109% | −$42.6M+21% | −$146.4M | −$55.9M+1154% |
| $161K | $381K−47% | $667K+755% | $1.5M+123% | $0 | −$420K | $0 | $685K−54% | $0 | $1M | −$144.5M | $84K−88% | |
| Net income | −$17.6M−29% | −$34.5M−29% | $21.6M | −$17.6M−27% | −$8.4M−53% | −$20.2M−42% | $13.9M−35% | −$3.2M−82% | −$18.7M+124% | −$25.9M+28% | $2.3M−83% | −$39M+1133% |
| −$0.29−33% | −$0.56−33% | $0.33 | −$0.28−30% | −$0.13−55% | −$0.31−45% | $0.20−39% | −$0.05−82% | −$0.27+108% | −$0.37+19% | $0.02−90% | −$0.42+740% | |
| 60.5M+6% | 61.2M+5% | 65.3M+11% | 63.1M+5% | 64M+6% | 64.8M+6% | 69.3M+6% | 68M+8% | 68.6M+7% | 69M+7% | 96.8M+40% | 92.8M+36% |
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 6 periods, Q4 FY20 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Brokers nearest Baldwin Insurance's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BWINBaldwin Insurance | $4.5B | n/m | n/a | n/m | 2.6× | +19% | −4.7% |
| CRVLCorvel | $4.2B | 37.3× | 38.1× | n/m | 4.3× | +7% | 11.7% |
| NPNeptune Insurance | $3.9B | 91.7× | 126× | n/m | 19.9× | +34% | 22.7% |
| HGTYHagerty | $5.4B | 260× | 50.9× | n/m | 3.7× | +8% | 1.8% |
| ACTEnact | $6.6B | 10.1× | 7.8× | n/m | 5.3× | +2% | 54.5% |
| RYANRyan Specialty | $11.2B | 60.7× | 92.3× | n/m | 3.5× | +14% | 3.1% |
| GSHDGoosehead Insurance | $1.7B | 39.8× | 175× | n/m | 4.3× | +18% | 8.8% |
| TWFGTWFG | $1.5B | 47.1× | 45.8× | n/m | 5.2× | +35% | n/m |
| ERIEErie Indemnity | $13.3B | 23.0× | 31.6× | n/m | 3.2× | +4% | 14.0% |
| BROBrown & Brown | $24.4B | 21.8× | 29.1× | 15.7× | 3.6× | +34% | 17.7% |
| WTWWillis Towers Watson Public | $30.2B | 19.9× | 26.0× | 15.5× | 3.0× | +3% | 15.5% |
| Peer median | $6B | 38.5× | 41.9× | 15.6× | 4.0× | +11% | 14.0% |
Investors who own it
Investors we follow who held Baldwin Insurance at the end of Jun 30, 2026, from their 13F filings.
- Ron BaronBaron Capital0.1% of portfolioadded
More on Baldwin Insurance
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #6of 19Insurance brokers with the fastest revenue growth
- #7of 21Insurance brokers with the lowest price to sales ratio
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .